Real World Retina: Challenges in the Management of Retinal Disease - Focus on Age-related Macular Degeneration

1.50 CME

90 MINS

SAVE

Overview

Provider Statement

This continuing medical education activity is provided by Vindico Medical Education

Support Statement

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Target Audience

The intended audience for this activity is retina specialists, ophthalmologists, and other health care professionals involved in the management of patients with retinal diseases.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

Evaluate the evidence for anti-VEGF treatment outcomes in age-related macular degeneration in clinical practice.
Identify prognostic indicators for predicting anti-VEGF therapy outcomes in patients with age-related macular degeneration.
Assess the applicability of recent advances in imaging for monitoring treatment response in patients with age-related macular degeneration.

Activity Chair

Carl D. Regillo, MD, FACS
Director, Retina Service
Wills Eye Hospital
Professor of Ophthalmology
Thomas Jefferson University
Mid Atlantic Retina
Philadelphia, PA

Faculty

Caroline R. Baumal, MD, FASRS
Professor of Ophthalmology
Tufts Medicine
New England Eye Center
Boston, MA

Rishi P. Singh, MD
Staff Physician and President
Cleveland Clinic Martin Hospitals
Stuart, FL
Professor of Ophthalmology, Lerner College of Medicine, Case Western Reserve University
Cleveland, OH

Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP

Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, December 30, 2022, to December 29, 2023.

How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 4 of the 5 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.

Disclosures

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Activity Chair and Faculty report the following relevant financial relationship(s)

Carl D. Regillo, MD, FACS
Consultant: 4DMT, Adverum, Aldeyra, Allergan Annexon, Apellis, Aviceda, Chengdu Kanghong, Clearside, EyePoint, Genentech, Graybug, Iveric Bio, Kodiak, Lineage, NGM Bio, Notal Vision, Novartis, Ocugen, Regenxbio, Stealth Bio, Théa
Independent Research Contractor: Adverum, Alderya, Allergan, Annexon, Apellis, Astellas, Chengdu Kanghong, Clearside, EyePoint, Genentech, Graybug, Iveric Bio, Kodiak, Lineage, NGM Bio, Novartis, Opthea, Regeneron, Regenxbio

Caroline R. Baumal, MD, FASRS
Consultant: Genentech, Novartis, Regeneron, Zeiss

Rishi P. Singh, MD
Consultant: Alcon, Apellis, AsclepiX, Bausch + Lomb, Genentech, Gyroscope, Iveric, Novartis, Regeneron

Reviewer reports the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relevant financial relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. © 2022 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.